Journal of Innovations in Pharmaceutical and Biological Sciences (JIPBS)
eISSN: 2349-2759 | pISSN: 2395-1095 | Vol. 3, Issue 4, 2016, pp. 125-132

Protective effect of Resveratrol against nephrotoxicity of nicotine in male rat: Antioxidant and histopathological approaches

Hayat A. A. Ismail1

1Department of Biology, Faculty of Science, King Abdel Aziz University, Jeddah, Saudi Arabia
DOI: 10.56511/JIPBS.2016.v3.i04.pp125-132 | Published: 2016-10-05 | Article page and PDF

Abstract

Background and Objective: The deleterious health effects of cigarette smoking are remaining the most important convertible risk factor for improving overall mortality. In addition to being a risk factor for kidney disease, there is strong evidence that demonstrating a role for cigarette smoking in the progression of chronic kidney disease (CKD). Nicotine can freely cross the biological membranes of body organs. Resveratrol is a compound which is a member of plant compounds called polyphenols which possess a free radical scavenger. The study aimed to evaluate the influence of Resveratrol (Res) in rat with Nicotine (Nic) induced nephrotoxicity, by evaluating the biochemical and histopathological changes. Methodology: The experiment was carried out on four groups of male rats as follows; The first group served as a control group, 2nd group was treated with Nic (2.5 mg kg-1) dissolved in physiological saline, 3rd group was received Res (20 mg Kg-1), 4th group was treated with combination of Nic (2.5 mg Kg-1) and Res (20 mg Kg-1). Results: The results indicated that Nic increased Uric acid, Urea, Creatinine, lipid peroxidation, TOS level and decrease the antioxidant enzymes as well as decrease the thiol and G6PD levels. A serious congestion, correlated with kidney was observed in Nic treatment and the role of Res in improving all the oxidative damage and the histopathological changes in kidney. In the light of the present results, it is evident that Res was able to reduce the nephrotoxic effect of Nic in male rats.

Keywords: Nicotine; Resveratrol; Kidney; Oxidative stress; Histopathology

*Corresponding Author: Dr. Hayat

-1 Res (20 mg Kg ). Results:

Introduction

The use of tobacco products is the leading preventable cause of death in the world today, resulting in nearly six million deaths annually and assisting in the manifestation of many other diseases [1]. In addition, the economic damages caused by tobacco smoking in the US alone over the past four decades could exceed $7 trillion USD.

Existing therapeutic treatments have proven to be more and more ineffective at assisting those with the desire to quit [2] and, if current trends continue, more than 1 billion people may die from smoking related diseases in the 21st century [1].

Nicotine is the main addictive compound found in tobacco products [3]. It has been shown to induce rewarding behavior through stimulation of brain mesolimbic dopamine neurons [4], prompting addiction and directly instigating the withdrawal symptoms experienced by those trying to quit [5].

nd -1 rd ) dissolved in physiological saline, 3 group was -1 th -1 ), 4 group was treated with combination of Nic (2.5 mg Kg ) and Resveratrol is a polyphenolic phytoalexin that naturally occurs in many plants, including grapevines and berries, and exhibits pharmacologic health benefits including antioxidants [6], antimutagenic [7], anti-inflammatory [8], anticancer [9] and cardioprotective properties [10]. Resveratrol is a natural polyphenol that has been found in several plants, such as grapevines, cranberries and peanuts. This polyphenol exerts many physiological effects in mammals, including anti-inflammatory, antioxidant activities [11]. The antioxidant activities of reservatrol have been widely studied and there are apparently several mechanisms of activity.

Resveratrol decreases the intracellular and extracellular production of reactive oxygen and nitrogen species [12]. Resveratrol elicits inhibitory effects at all stages of the inflammatory response: it modifies the activity of inflammatory cells by inhibiting production of reactive oxygen and nitrogen species; it regulates enzyme expression, and it decreases the activity of several enzymes involved in the synthesis of proinflammatory mediators [13]. This polyphenol has effects on cell signaling pathways involved in inflammation.

It was imperative to investigate the effects of nicotine administration and these interactions with resveratrol supplementation.

Materials and methods

Chemicals

All reagents were of the highest purity available. Nicotine hydrogen bitartrate was obtained from Sigma Chemical Company, St.- Louis, Missouri, USA. All other chemicals and reagents used were of analytical grade. Other chemicals for measurements were purchased from Sigma Chemical Company, St. Louis, MO, USA, transResveratrol (>98% purity) was obtained from Cayman Chemical Company (Ann Arbor, MI, USA).

Animals

Male albino Wistar rats, of 8 weeks of age and weighing about 150–180 g, were obtained from the king Fahad center for scientific purposes - King abdulaziz university, Jeddah , Saudi Arabia. Animals were housed into a polypropylene cage and provided with food and water ad libitum. Before beginning the experiment, all animals were acclimated for 2 weeks under well-controlled conditions of temperature (22- 25ºC) and a 12/12 h lightdark cycle. Animals were fed standard pellet diet.

Routes of administration and Experimental design

The dosages of the two chemicals were determined according to Kalpana and Menon [14] and Oktem et al. [15]. Rats were randomly distributed into four groups (n=10). And received their respective intraperitoneally (i.p) treatment for 4 weeks for sub-chronic study as st follows:1 group served as non-treated control group - which received physiological saline (NaCl 9%) (1 ml kg 1 nd ), 2 group treated with Nic (2.5 mg kg -1) dissolved in rd physiological saline, 3 group treated with Res in a dose th of (20 mg Kg-1).Finally , 4 group was treated with Nic plus Res at the same doses.

Blood collection

Blood samples of the fasted rats were collected from the medial retro-orbital venous plexus immediately with capillary tubes (Micro Hematocrit Capillaries, Mucaps, Jiangsu, China (Mainland) under ether anesthesia Boussarie [16]. Then, the blood was centrifuged at 1000 xg for 15 min and serum was collected for different biochemical analyses.

Tissue preparation

A kidney tissue (about 0.25 g) was used for the analysis of oxidative stress parameters.

Prior to dissection, tissue was perfused with a 50 mM (sodium phosphate buffer saline (100 mM Na2HPO4 /NaH2PO4) (pH 7.4) and 0.1 m ethylenediamine tetraacetic acid (EDTA) to remove any red blood cells and clots. Then, tissues were homogenized in 5 mL cold buffer per gram tissue and centrifuged at 2700 xg for 1hr. The resulting supernatant was transferred into Eppendorf tubes and preserved in a deep freeze until used for various oxidative assays.

Total antioxidant status assay (TAS)

Total antioxidant status (TAS) was measured in kidney using a commercially available kit from Rel Assay Diagnostics (Gaziantep, Turkey) Erel [17]. The method was based on the reduction of colored 2,20-azino-bis(3- ethylbenzotiazoline-6-sulfonic acid) (ABTS) radical to a colorless reduced form by antioxidants present in the sample. Absorbance was measured spectrophotometrically at a wavelength of 660 nm. Data were expressed as mmol Trolox equivalent (eq.) per liter (mmol Trolox eq./L).

Total oxidant status assay (TOS)

Total antioxidant status (TOS) was measured in kidney using a commercially available kit from Rel Assay Diagnostics Erel [18]. The method was based on the principle that the oxidants in the sample oxidized ferrous ions, previously bounded to a chelator, to ferric ions. The color intensity was measured spectrophotometrically at a wavelength of 530 nm and the results were expressed as l mol H2O2 eq./L.

Determination of oxidative and antioxidant parameter

Lipid peroxidation was determined by the procedure of Esterbauer and Cheeseman [19]. Tissue supernatant thiobarbituric acid-reactive substances (TBARS) were measured at 532 nm by using 2-thiobarbituric acid (2,6- dihydroxypyrimidine-2-thiol; TBA)MDA concentrations were determined using 1,1,3,3-tetraethoxypropane as standard and expressed as μmol/g tissue.

Superoxide dismutase (SOD) activity was measured according to the method described by Marklund and Marklund [20] by assaying the auto oxidation of pyrogallol at 440 nm for 3 min. One unit of SOD activity was calculated as the amount of protein that caused 50% pyrogallol autooxidation inhibition. A blank without homogenate was used as a control for non-enzymatic oxidation of pyrogallol in Tris–EDTA buffer (50 Mm Tris, 10 mM EDTA, pH 8.2). The SOD activity is expressed as U/mg protein.

Catalase (CAT) activity was measured, determined according to the method described by Aebi [21] by assaying the hydrolysis of H O and the resulting 2 2 decrease in absorbance at 240 nm over a 3 min period at 25˚C. Before determination of the CAT activity, samples were diluted 1:9 with 1% (v/v) Triton X-100. CAT activity is expressed as mmol/mg protein.

Glutathione peroxidase (GPx) activity was determined by the assay described by Hafeman et al. [22]. The peroxide substrate (ROOH), GRx and NADPH are included in the reaction mixture. The formation of the oxidized form of glutathione (GSSG) that is catalyzed by GPx is coupled to the recycling of GSSG back to the reduced form of glutathione (GSH) using GRx. NADPH is oxidized to + NADP . The change in A 340 due to NADPH oxidation is monitored and is indicative of GPx activity. The activity of GPx was expressed in terms of mmol GSH consumed/min/g wet weight tissue Total antioxidant capacity was determined using ferric reducing antioxidant power assay according to the method of Prieto et al. [23]. FRAP reagent (300 mM acetate buffer, pH 3.6, 10 mM 2,4,6-Tri (Z-pyridy)-S (riazine, 99 %) (TPTZ) in 40 mM HCl and 20 mM FeCl .6H O in the ratio of 10:1:1 was prepared. 1.5 mL 3 2 FRAP reagent was added to 50 μL of homogenated kidney tissues and incubated at 37 ºC for exactly 5 min. The change in absorbance was measured at 593 nm due to the formation of a blue colored FeII-tripyridyltriazine III complex from the colorless oxidized Fe form by the action of electron donating antioxidants. The absorbance of the sample was read against reagent blank (1.5 mL FRAP reagent and 50μL distilled water) at 593 nm.

Xanthine oxidase (XO) activity was assayed spectrophotometrically by the reaction of enzyme with xanthine, as a substrate, and the absorbance was measured at 650 nm, according to the method described in Kamel and Hamed, [24]. In two test tubes, 15 μl phosphate buffer (0.1 M, 7.4 pH) and 30 μl water (control) or substrate (test; xanthine, 38 mM, dissolved in distilled water by adding alkali and gentle heating) was added to 0.5 ml homogenates (Kidney) and incubated for 40 min at 37 °C. Then, 0.1 ml of this solution was mixed with 0.1 ml Na-tungstate 40%, 0.5 ml water and 0.1 ml 2N H2SO4 complete to 1 ml and incubated for 1 h at 37°C then centrifuged at 3000 rpm for 10 min. 0.15 ml of supernatant was mixed with 0.75 ml water, 0.3 ml Foline reagent and 1.5 ml saturated Na-carbonate solution. The absorbance was measured at 650 nm after 10 min. XO activity was determined using the following equations: Concentration of xanthine in control or test = A (sample) /A (standard) × concentration of standard × 48. Xanthine oxidase activity (U/g tissue) = concentration of test concentration of control/0.284.

Determination of glucose-6 phosphate dehydrogenase (G6PD)

Tissue glucose-6-phosphate dehydrogenase (G6PD) activities were measured in kidney homogenates using the methods described by Deutsch Aebi [21]. The results were expressed as U/g protein.

Determination of non enzymatic antioxidant (Thiol level)

Total thiols level was determined according to Hu [25]. An aliquot of kidney homogenate (50 mL) was mixed with 1 mL of Tris base (0.25 M) – EDTA (20 mM) buffer, pH 8.2, and the absorbance at 412 nm was determined. To this was added 20 mL of 10 mM DTNB. After 15 min at ambient temperature, the absorbance was measured again with DTNB blank. Results are expressed in [mM].

Histological evaluation

For histological examination, a portion of the kidney was fixed in 10% neutral buffered formalin embedded in paraffin, sectioned and stained with Haematoxylin and Eosin as described by Gabe [26]. Then semi-thin sections (0.5-1 microns) were prepared by using LKB ultra microtome. The sections were stained with toluidine blue, examined with a light microscope and photographed.

Results

As shown in table 1 uric acid, creatinine and urea were significantly increased (p< 0.05) in Nic treated group alone. Treating the rats with the Res afforded non-significant changes in uric acid, urea and creatinine levels as compared to normal control group. All kidney function parameters had depressed significantly (p < 0.01) in the kidney tissues of Nic/Res treated group as compared to Nic treated group by 49, 53.75, and 44.34% in uric acid, creatinine and urea respectively.

Table 1. Effect of Nicotine and/or Resveratrol on some kidney functions in male rats

Nic: Nicotine; Res: Resveratrol, Values are expressed as means SE; n = 10 in each treatment group. Significant differences are arranged alphabetically from

Parameters Uric acid Creatinine Urea (mg) (mg) (mg) cd d c Control group 22.09±1.25 0.48±0.98 18.01±3.65 a a a Nic group 68.04±1.02 2.66±1.65 44.29±2.52 d cd c Res group 21.11±2.35 0.59±2.24 17.84±2.14 b b b Nic +Res group 34.70±1.98 1.23±1.02 24.65±2.69

higher to lower.

All the parameters of antioxidant enzymes (SOD, CAT, and GPx) were decreased when the male rats were exposed to the dose of Nic (Table 2). Administration of Res to the Nic-treated group with dose (2.5 mg Kg-1) had restored SOD, GPx, and CAT significantly (p < 0.05) as compared to Nic treated group alone. Treating the male rats with the Nic decreased the activity of SOD that has been increased again when Nic group has been treated with Res for 4 weeks. The activity of CAT had depressed significantly (p < 0.01) in the renal tissues of Nic treated

Table 2. Effect of Nicotine and/ or Resveratrol on some antioxidant /oxidative stress parameters in kidney of male rat Parameters SOD (U g ) CAT (U g ) GPx (U g ) MDA (U g ) TCA % XO (U g )
Table 2. Effect of Nicotine and/ or Resveratrol on some antioxidant /oxidative stress parameters in kidney of male rat Parameters SOD (U g ) CAT (U g ) GPx (U g ) MDA (U g ) TCA % XO (U g )

The same observation has been noticed in the GPx activity that decreased by Nic treated group and increased by the treatment of the rat with Res after Nic.

To investigate the oxidative stress in renal tissues, Table 2 represents the levels of MDA (index of lipid peroxidation) in normal and treated rats. It was found that MDA levels in Nic treated rat were increased in renal tissues by approximately 57.40 -fold as compared to control after 4 weeks of treatment with Nic. The values of TAC were 94 %, 73.80%, 93.84% and 83.20 % for control, Nic, Res and Nic and Res respectively table 2.

Table 2 showed that XO activity was increased significantly in Nic treated group by 11.17-fold as compared to control group. Meanwhile, combination of Res with Nic afforded a significant decrease in XO activity as compared to Nic treated group and elicited a significant increase as compared to normal control group.

-1 -1

Table 3. Effect of Nicotine and/ or Resveratrol on TAS and TOS levels in kidney of male rat
Table 3. Effect of Nicotine and/ or Resveratrol on TAS and TOS levels in kidney of male rat

Nic: Nicotine; Res: Resveratrol; SOD: superoxide dismutase; CAT: catalase; MDA: malondialdehyde; XO: xanthine oxidase; NO: nitrite; TAC: total antioxidant capacity. Values are expressed as means SE; n = 10 in each treatment group.

Significant differences are arranged alphabetically from higher to lower

Table 4. Effect of Nicotine and/ or Resveratrol on Thiol (SH) (mmole/ml ) and G6PD (U/g) levels in kidney of male rat Parameters Thiol (mmole/ml) G6PD (U/g)
Table 4. Effect of Nicotine and/ or Resveratrol on Thiol (SH) (mmole/ml ) and G6PD (U/g) levels in kidney of male rat Parameters Thiol (mmole/ml) G6PD (U/g)

Nic: Nicotine; Res: Resveratrol; Values are expressed as means SE; n = 10 in each treatment group. Significant differences are arranged alphabetically from higher to lower.

Data presented in (Table.3) showed that treatment of the male rat with Nic caused a significant decrease in the level of TAS. It decreased by1.07 fold as compared to control group. However, the concurrent administration of Res to the rat treated with Nic significantly (p < 0.001) increased the level of TOS as compared to its related group. But the levels were restored to near to normal values in group treated with Nic and Res respectively in both parameters (TAS and TOS) levels.

Thiol and G6PD levels were decreased by 3.08 -folds in Nic treated rat (Table. 4). Co-administration of Res with Nic practically prevented the changes in G6PD levels. Thiol level was decreased by 29.82% in Nic treated group as compared to control group and the thiol value was increased in Res treated group and Nic/Res treated group as compared to Nic treated group.

-1 -1 -1

Histological finding

The histopathological changes in kidney after 4 weeks of Nic or/and Res treatment are presented in Figure 1 (A-D). All control rat and Res group had normal renal tissues with normal renal tubules formed of normal glomeruli surrounded by normal proximal and distal renal tubules (Figure 1A-1C). The renal tissues in Nic group had showing dilated congested vascular space and aggregated of inflammatory cells between the renal tubules (Figure 1B). Evident histological alterations in Nic + Res treated group already appeared 4 weeks after the treatment, showing mild condensed glomerulus and mild aggregates of inflammatory cells (Figure 1D). These modifications were more evident to the oxidative stress that has been taken place in renal tissues of Nic treated group.

Table 5 showed the recording of different histopathological findings in different slides obtained from the four different groups and the variation from absence of change ----+, change that was observed in almost groups +++-, change that is often observed in all animals ++- till the change that is often found ++++.

Figure 1. Effect of Resveratrol and Nicotine on renal tissues. (A) Control group: Histological section from control with
Figure 1. Effect of Resveratrol and Nicotine on renal tissues. (A) Control group: Histological section from control with

normal renal tissues formed of normal glomeruli (Black arrow) surrounded by normal proximal and distal renal tubules (**) (H&E x Photomicrograph of renal tissues exposed to Nic showing dilated congested space (*) and aggregated of inflammatory cells (Black arrow) between the renal tubules (H&E x 400).

tissues formed of normal glomeruli (Black arrow) surrounded by normal proximal and distal renal tubules Photomicrograph of renal tissues treated with Nic + Res showing mild condensed glomerulus (Black arrow) and mild aggregates of inflammatory cells (**) (H&E x 400).

Table 5. Histopathological findings in kidney of rats treated with Nicotine and Resveratrol Findings Groups Control Nicotine Resveratrol Nicotine + Resveratrol
Table 5. Histopathological findings in kidney of rats treated with Nicotine and Resveratrol Findings Groups Control Nicotine Resveratrol Nicotine + Resveratrol

A change which was often found in all the studied animals of a group.

A change which was observed in almost all the studied animals of a A change not so often observed in all animals of a group.

A change which was rare within a group 400); (B) Nicotine group:

Nicotine + Resveratrol group:

++++ +++- ++– —+ (C) Resveratrol group: Photomicrograph of normal renal (H&E x 400). (D) group.

Discussion

Cigarette smoking causes stimulation in the sympathetic system, and an increase in blood pressure and heart rate leading to an increase of plasma concentrations of norepinephrine and epinephrine; these effects are intermediated by nicotine, and are seen in cigarettes with nicotine [27].

Administration of nicotine leads to significant increment in blood pressure accompanied by a decrease in glomerular filtration rate (GFR) [28]. It has been proposed that the response of the kidney can be impaired due to the increased blood pressure may in smokers, leading to an increase in GFR and possibly also increased intraglomerular pressure, compared to non-smokers who have the normal reno-protective decrease in GFR and renal plasma flow in the same scenario [29].

There is a vast evidence supporting the deleterious effects of cigarette smoking on renal function, with a significant impact on health care outcomes, as well as health care economics. The last decade has seen several significant studies to strongly suggest the role of cigarette smoking in progression of renal dysfunction. The effects of smoking start at an early age, and have long lasting effects. The increasing prevalence of chronic kidney disease calls for the progression of CKD and these previous findings support the obtained results in the current study as Nic induced a deleterious effects on kidney function parameters and oxidative stress as compared to control group and Res combined group with Nic which prove the beneficial effects of Res in reducing the side effects of Nic especially on kidney functions. This is particularly important as patients with chronic kidney disease are also at risk for significant cardiovascular disease, and smoking offer a combined cardiovascular as well as renal dangerous [30]. Further studies are underway to investigate the mechanisms of nicotine induced renal injury, as well as possible ways to prevent this renal dysfunction.

The doses of Nic that was used induced significant oxidation status and histological modifications in the kidney. The increased LPO and TOS concentration, while decreasing TAS level observed in this study resulted from oxidative damage to the renal tissues after Nic-treatment. It is evident that Nic caused prooxidative activity.

Nicotine, once absorbed, is mainly metabolized by the liver to a number of major and minor metabolites [31, 32]. It has been considered highly susceptible organs to free radical generation and toxic effect of nicotine. In fact, numerous experimental and clinical evidences have been shown that nicotine through smoking induces an inflammatory response in the lung [33], promote pathogenesis of obstructive pulmonary diseases [34] and thus the new concept in the present study is the effect of nicotine on renal tissues from the oxidation aspect and histopathological approach through measuring also thiol and G6PD levels which are new concepts in the present finding and confirming the occurance of cell damage in Nic treated group which is diminished by administration of Res and thus proving its antioxidant activity.

In accordance with the present study findings, numerous investigations have revealed that nicotine treatment might augment toxicity and oxidative damage in rat tissues [35]. In reality, it has been demonstrated that nicotine as individual source for ROS production [36, 37] cause oxidative damage to important components of the cellular machinery [35]. In this respect and for the increasing rate of co-use and co-abuse of smoking cigarette [38, 39]. Resveratrol is a compound obtained from the roots of the Polygonum cuspidatum plant used in traditional Eastern medicine for the treatment of fungal diseases, skin inflammation, and cardiovascular and liver diseases [40]. Resveratrol is a phenolic phytoalexin [41] that occurs naturally in various foods, including grapes, plums, cranberries, and peanuts.

Its antioxidant effects have been demonstrated in the kidneys [42]. Res is a free radical scavenger that increases the activity of several antioxidant enzymes [43] and the present finding revealed its antioxidant activity against spleen toxicity induced by nicotine in male rats and this appear greatly and consequently through increasing the level of antioxidant enzymes and decreasing the final product of lipid peroxidation which reflect the antioxidant ability of Res against toxicity of Nic.

The present findings concides with obtained by Leonard et al.,[43] as Res is a free radical scavenger that increases the activity of several antioxidant enzymes. Resveratrol (3,5,40-trihydroxystibene) possesses antioxidant activity, due to its polyphenolic structure. It exists as trans-and cisisomers. The trans-isomer is the naturally occurring form produced by plants and it is converted to the cis-isomer under exposure to light.

It was imperative to investigate the effects of nicotine administration and these interactions with resveratrol supplementation.

The obtained results came in accordance with that obtained by Mosbah et al., [44] who reported that Nicotine is an active substance present in tobacco that causes oxidative stress and tissues damages leading to several diseases. Natural antioxidants that prevent the progression and severity of nicotine toxicity may have a significant health impact. They used green tea extract against nicotine toxicity and they proved that green tea extract played a protective role against nicotine-induced oxidative stress.

The present work also showed that the changes in LPO were accompanied by a concomitant decrease in the activities of antioxidant enzymes, namely SOD, CAT and GPx after 4 weeks of Nic treatment in renal tissues. SOD, enzymes which provide a defense against the intermediates of dioxygen.

SOD constitutes an important link in the biological defense mechanism through dismutation of endogenous cytotoxic superoxide radicals to H2O2 and O2.–, which are deleterious to polyunsaturated fatty acids and proteins [45].

Nic administration to male rats induces free radical generation and hence the first line defense comes to the rescue as shown by the significant decrease in SOD in Nic-animals. Moreover, the reduced in CAT or GPx activity to degrade H O , more H O could be converted 2 2 2 2 to toxic hydroxyl radicals that may contribute to oxidative stress due to Nic as shown before in methanol intoxication with antioxidant enzymes [46].

A decline in the activities of these enzymes could be due to their inactivation by excess ROS production. The antioxidant enzymes CAT and GPx protect SOD against inactivation by H O . Reciprocally, SOD protects CAT 2 2 and GPx against superoxide anion. The role of H O in 2 2 ROS generation has been observed in other studies [47]. In the present study, the activity of GPx decreased as the effect of Nic. A reduction in GPx activity results in increased H O levels and hence severe cellular damage is 2 2 observed in renal tissue.

Free radicals initially increase due to induction of Nic as the levels of NO and LPO increased as well as the activity of XO. LPO is associated with a wide variety of toxic effects, including decreased membrane fluidity and function, impaired functions of the mitochondria and Golgi apparatus and inhibition of enzymes.

The results of the present study go parallel with the results obtained by Salahshoor et al. [48] who indicated the effect of nicotine on vital organs and decreasing its antioxidant activity.

In accordance with the obtained results, Zhou et al., [49] reported that nicotine stimulated apoptosis and it was observed that Nic are responsible for apoptosis related cell death.

The present results are in parallel with the previous results obtained by Sener et al., [50] Chronic administration of nicotine has been described to be nephrotoxic in the rat. Indeed, nicotine accumulates preferentially in the kidney, where it creates an imbalance between the release of lipid peroxidation products and the endogenous antioxidant activity.

The current data are in accordance with Claude et al., [51] who reported that Nic induced tubular damage score and histology of the kidney showed degeneration of kidney glomerulus.

Histological studies showed deleterious effects of nicotine on kidney. Urea showed a significant increase Nicotine treated group. These results indicate that nicotine exposure increase the risk of damage that occurs in the kidney with increasing the period of exposure to nicotine [52] which is in accordance with the current finding.

The current results are incomplete agreement with Ghada et al., [53] who demonstrated that histological examination of nicotine-treated group rat kidneys, revealed marked tissue damage. The proximal and distal convoluted tubules showed partial destruction of the brush border of the proximal convoluted tubules and desquamated cells were observed inside their lumens. Apparent thickening of the basement membrane of the distal convoluted tubules was also found. Small pyknotic nuclei and collapsed necrotic glomerulus were present. There were irregular shapes of the nuclei of some tubular cells with dilation of glomerulus which is as the same of the obtained results.

Conclusion

Resveratrol had found to exert ameliorative effect on antioxidant parameters of the renal tissues. The present study indicates that a decrease in the antioxidant status is one of the main factors contributing to Nicotine toxicity to the kidney. The observed significant increase in the LPO and oxidative stress markers as well as XO activities in the renal tissues of Nic-exposed animals, suggests that the tissues are subjected to increased oxidative stress. Reversible oxidative/antioxidant and histological modifications were observed when Res used after Nic treatment. Res treatment found to remove the continuously generated free radicals, to prevent the endogenous antioxidant enzymes decrease and act to prevent oxidative cell damage induced by Nic.

References

References

  1. World Health Organization, 2013. WHO Report on the Global Tobacco Epidemic, 2013: Enforcing Bans on Tobacco Advertising, Promotion and Sponsorship.(in IRIS). World Health Organization, Geneva.
  2. Messer K, Trinidad DR, Al-Delaimy WK, Pierce JP: Smoking cessation rates in the United States: a comparison of young adult and older smokers. Am. J. Public Health 2008; 98:317–322.
  3. Benowitz N: Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu. Rev. Pharmacol. Toxicol 2009; 49:57–
  4. Corrigall WA, Franklin KB, Coen KM, Clarke PB: Themesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 1992; 107:285–289.
  5. De Villiers SH, Lindblom N, Kalayanov G, Gordon S, Baraznenok I, Malmerfelt A, Marcus MM, M.Johansson A, Svensson TH: Nicotine hapten structure, antibody selectivity and effect relationships: results from a nicotine vaccine screening procedure. Vaccine 2010; 28:2161–2168.
  6. Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, Shi X: Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses, Biochem. Biophys. Res. Commun 2003; 309:1017– 1026.
  7. Uenobe F, Nakamura S, Miyazawa M: Antimutagenic effect of resveratrol against Trp-P-1, Mutat. Res 1997; 373:197–200.
  8. Bertelli AA, Ferrara F, Diana G, Fulgenzi A, Corsi M, Ponti W, Ferrero ME, Bertelli A: Resveratrol, a natural stilbene in grapes and wine, enhances intraphagocytosis in human promonocytes: a co-factor in antiinflammatory and anticancer chemopreventive activity, Int. J. Tissue React 1999; 21:93–104.
  9. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y: Role of resveratrol in prevention and therapy of cancer:
  10. Das S, Das DK: Resveratrol: a therapeutic promise for cardiovascular diseases, Recent Pat. Cardiovasc. Drug Discov 2007; 2:133–138.
  11. Brisdelli F, D'Andrea G, Bozzi A: Resveratrol: a natural polyphenol with multiple chemopreventive properties. Curr Drug Metab 2009; 10:530–46.
  12. Leiro J, Alvarez E, Arranz JA, Laguna R, Uriarte E, Orallo F: Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. J Leukoc Biol 2004; 75:1156–65.
  13. De la Lastra CA, Villegas I:Resveratrol as an anti-inflammatory and antiaging agent: mechanisms and clinical implications. Mol Nutr Food Res 2005; 49:405–30.
  14. Kalpana C, Menon VP: Protective effect of curcumin on circulatory lipid peroxidation and antioxidant status during nicotine-induced toxicity. Toxicol Mech Methods 2004; 14:339–43.
  15. Oktem G, Uysal A, Oral O, Sezer ED, Olukman M, Erol A: Resveratrol attenuatesdoxorubicin-induced cellular damage by modulating nitric oxide and apoptosis. Exp Toxicol Pathol 2012; 64:471–9.
  16. Boussarie D: Hématologie des rongeurs et lagomorphes de compagnieBull. Acad. Vét. De France 1999;72: 209-216.
  17. Erel O: A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin. Biochem 2004; 37: 277–285.
  18. Erel O: A new automated colorimetric method for measuring total oxidant status. Clin. Biochem 2005; 38:1103–1111.
  19. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407–421.
  20. Marklund S, Marklund G: Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase". Europ. J. Biochem 1974; 47: 469–474.
  21. Aebi DJ: Glucose-6-phosphate dehydrogenase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. 2nd ed. Weinheim: VCH Verlagsgesellschaft mbH 1986; 190–6.
  22. Hafeman D, Sunde G and Hoekstra WG: Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J. Nulr 1974; 104:580-587.
  23. Prieto P, Pineda M, Aguilar M: Spectrophotometric quantitation of antioxidant capacity through the formation of a Phosphomolybdenum complex specific application to the determination of vitamin E. Anal. Biochem 1999; 269:337–341.
  24. MY, Hamed RR: colorimetric method for the determination of guanine and xanthine and its application to the assay of xanthine oxidase, Microchemical Journal 1980; 25(3): 323-329.
  25. Hu ML: Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994; 233:380–5.
  26. Gabe M: Techniques histologiques [Histological Techniques]. Paris: Masson Publisher 1968.
  27. Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M: Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994; 90:248–53.
  28. Halimi JM, Philippon C, Mimran A: Contrasting renal effects of nicotine in smokers and non-smokers. Nephrol Dial Transplant 1998; 13:940–4.
  29. Orth SR: Effects of smoking on systemic and intrarenal hemodynamics: influence on renal function. J Am Soc Nephrol 2004; 15(Suppl 1):S58–
  30. Orth SR, Stockmann A, Conradt C, Ritz E, Ferro M, Kreusser W:Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 1998; 54:926–31.
  31. Yildiz D: Nicotine, its metabolism and an overview of its biological effects. Toxicon 2004; 43:619–32.
  32. Snyder MJ, Hsu E, Feyereisen R: Induction of cytochrome P-450 activities by nicotine in the tobacco hornworm, manduca sexta. J Chem Ecol 1993; 19: 2903–10.
  33. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, J.Barnes P: Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J 2003; 21(4):589–93.
  34. Hackett NR, Heguy A, Harvey BG, Kalpan R: Variability of antioxidant related gene expression in the airway epithelium of cigarette smokers. Am J Respir Cell Mol Bio 2003; 29(3):733–44.
  35. Anthony JC, Echeagaray-Wagner F: Epidemiologic analysis of alcohol and tobacco use. Alcohol Res Health 2000; 24:201–8.
  36. Falk DE, Yi HY, Hiller-Sturmho¨ fel S: An epidemiologic analysis of cooccurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on alcohol and related conditions. Alcohol Res Health 2006; 29: 162–71.
  37. Mamdouh Y, Kamel R, Ragaa H: A colorimetric method for the determination of guanine and xanthine and its application to the assay of xanthine oxidase, Microchemical Journal 1980; 25(3):323-329.
  38. Sekhon H, Proskocil BJ, Clark JA: Spindel ER. Prenatal nicotine exposure increases connective tissue expression in fetal monkey pulmonary vessels. Eur Respir J 2004; 23:906–15.
  39. Schievelbein H, Balfour DJK: Nicotine and the tobacco smoking habit. Oxford: Pergamon Press 1984:1–15.
  40. Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S,: Effects of stilbene components of the roots of Polygonum cuspidatum Sieb et Zucc on lipid metabolism. Chem. Pharm. Bull 1982; 30: 1776–1770.
  41. Wang Y, Catana F, Yang R, Roderick R, Van Breemen RB:Analysis of resveratrol in grape products, cranberry juice and wine using liquid chromatography-mass spectrometry. J. Agric. Food Chem 2002; 50:431–
  42. Silan C, Uzun O, Comunog˘lu NU, Golcen S, Bedirhan S, Cengiz M: Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of resveratrol. Biol. Pharm. Bull 2007; 30:79–83.
  43. Leonard S, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, Shi X: Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun 2003; 309:1017– 1026.
  44. Mosbah R, Yousef MI, Mantovani A: Nicotine-induced reproductive toxicity, oxidative damage, histological changes and haematotoxicity in male rats: The protective effects of green tea extract. Experimental and Toxicologic Pathology 2015; 67(3): 253-259.
  45. El-Shenawy NS, AL-Harbi MS, Hamza RZ: Effect of vitamin E and selenium separately and in combination on biochemical, immunological and histological changes induced by sodium azide in male mice. Experimental and Toxicologic Pathology 2014; 67: 65–76.
  46. Hamza RZ, Ismail HAA, Khaled HE, El-Shenawy NS: Antioxidant effect of Lcysteine on sodium-valproate-induced oxidative stress in rat liver: biochemical and ultrastructural approaches. Toxicological and Environmental Chemistry 2015: 97(8): 1041-1056.
  47. Paula ME, Mathangi DC, Namasivayam A: Free radical changes in methanol toxicity. Indian Journal of Physiology and Pharmacology 2003; 47:207-211.
  48. Salahshoor M, Mohamadian S, Kakabaraei S, Roshankhah S, Jalili C: Curcumin improves liver damage in male mice exposed to nicotine. Journal of Traditional and Complementary Medicine 2016: 6(2): 176-183.
  49. Zhou X, Sheng Y, Yang R, Kong X: Nicotine promotes cardiomyocyte apoptosis via oxidative stress and altered apoptosis-related gene expression,Cardiology 2010;115 : 243–250.
  50. Sener G, Sehirli O, Ipci Y, Cetinel S, Cikler E: Protective effects of taurine against nicotine-induced oxidative damage of rat urinary bladder and kidney. Pharmacology 2005; 74: 37–44.
  51. Claude S, Gwen T, Geurt S, Carole K, Nike C, Fabrice M, Patrizia L, Bilo D, Luc B, Michel G, Sandrine F, Alain L: Nicotine Protects Kidney from Renal Ischemia/Reperfusion Injury through the Cholinergic AntiInflammatory Pathway. PLoS ONE 2007; 2(5): e469. doi:10.1371/journal.pone.0000469.
  52. Khadija M, Al-Khawaja MA, Nahla AH: The effect of nicotine on the liver and kidney of prepubertal Sprague Dawley rats. The FASEB Journal 2008; 22:1123.8.
  53. Ghada S, Mahmoud SAA: Protective Effects of Vitamin C against Nicotine-Induced Oxidative Damage of Rat Liver and Kidney. IOSR Journal of Environmental Science, Toxicology and Food Technology 2014; 8(12):2319-2399Ver. IV :50-63.